Biotech & pharma
New drug could cure nearly any viral infection
By By Anne Trafton, MIT News Office | 10 Aug 2011
Researchers at MIT’s Lincoln Lab have developed technology that may someday cure the common cold, influenza and other ailments.
Potential new eye tumour treatment discovered
08 Aug 2011
Brain training increases dopamine release
06 Aug 2011
Disease-causing tangle could spawn new materials
01 Aug 2011
Beefing up muscles can reduce diabetes risk
29 Jul 2011
Now, gastric bypass surgery to shed weight
27 Jul 2011
A growing number of obese patients are choosing to undergo bariatric surgery in order to lose weight
Are cancers newly evolved species?
27 Jul 2011
Tumour cells go against the flow
By By Alissa Mallinson, Mechanical Engineering | 23 Jul 2011
Microfluidic model helps explain how fluid’s flow in bodily tissue influences tumour cell migration.
Mapping of 'sixth nucleotide' in embryonic stem cells indicates it may activate genes
By By Kim Irwin | 23 Jul 2011
The finding by researchers may prove to be important in controlling diseases like cancer, in which the regulation of certain genes plays a role in disease development.
New lung cancer gene found
20 Jul 2011
The biology behind alcohol-induced blackouts
20 Jul 2011
Making blood-sucking deadly for mosquitoes
19 Jul 2011
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
